NASDAQ · ABSI
Absci Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ABSI: Nov 12, 2026
Absci Corporation Common Stock is expected to report earnings on 11/12/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.14. The reported EPS for the same quarter last year was $-0.2.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.14 | $-0.14 | $-0.14 | 1 |
| Dec 2026 | $-0.18 | $-0.18 | $-0.18 | 1 |
| Mar 2027 | $-0.14 | $-0.14 | $-0.14 | 1 |
| Jun 2027 | $-0.16 | $-0.16 | $-0.16 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
BNK Invest · Fintel · The Motley Fool · Zacks- BNK Invest · Oct 30, 10:58 AM EDTARKG, TXG, TEM, ABSI: ETF Outflow AlertLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ARK Genomic Revolution ETF (Symbol: ARKG) where we have detected an approximate $148.8 million dollar outflow — that's a 6.0% decrease week over we
- BNK Invest · Oct 21, 12:02 PM EDTWednesday's ETF Movers: WSML, KWEBIn trading on Wednesday, the iShares MSCI World Small-Cap ETF is outperforming other ETFs, up about 3.7% on the day. Components of that ETF showing particular strength include shares of Absci, up about 8.4% and shares of 10x Genomics, up about 8.4% on the day. And underperform
- BNK Invest · Sep 17, 12:05 PM EDTThursday's ETF Movers: ARKG, SIXAIn trading on Thursday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 8.5% on the day. Components of that ETF showing particular strength include shares of Absci, up about 18.9% and shares of Schrodinger, up about 17.3% on the day. And underperforming ot
- Fintel · Sep 10, 5:39 PM EDTLifeSci Capital Initiates Coverage of Absci with OutperformFintel reports that on September 9, 2026, LifeSci Capital initiated coverage of Absci (NASDAQGS:ABSI) with a Outperform recommendation. On the date of this rating action, September 9, 2026, the latest close for Absci was $8.65, following a pre-action close of $8.91 on September 8
- The Motley Fool · Aug 19, 9:52 AM EDTAbsci (ABSI) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 18, 3:43 AM EDTThe Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and AbsciAI is reshaping drug discovery, with Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci advancing computational platforms and pipelines.
- Zacks · Aug 17, 9:56 AM EDT4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes PharmaRXRX, SDGR, RLAY and ABSI are using AI-powered platforms to transform drug discovery while advancing proprietary clinical pipelines.
- MarketBeat · Aug 11, 6:04 PM EDTAbsci Q2 Earnings Call Highlights2 Reasons Absci Could Be the Future of AI Biotech, and 1 RiskAbsci (NASDAQ:ABSI) outlined progress in its clinical program for ABS-201, a prolactin receptor-targeting antibody being studied for pattern hair loss and planned for development in endometriosis, while reporting a larg
- Zacks · Jul 30, 9:40 AM EDTAre Medical Stocks Lagging ABSCI CORP (ABSI) This Year?Here is how Absci Corporation (ABSI) and Acadia Healthcare (ACHC) have performed compared to their sector so far this year.
- Zacks · Jul 17, 10:42 AM EDTViking Therapeutics to Report Q2 Earnings: What's in Store for the Stock?VKTX's Q2 report could hinge on VK2735 pipeline updates as investors await progress on obesity studies and maintenance dosing plans.
- Zacks · Jul 13, 9:55 AM EDTWall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should KnowThe average of price targets set by Wall Street analysts indicates a potential upside of 28.3% in ABSCI CORP (ABSI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- Zacks · Jul 2, 12:00 PM EDTHere's Why Absci Corporation (ABSI) is a Great Momentum Stock to BuyDoes Absci Corporation (ABSI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Absci Corporation from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.